

Your Money with Michelle Martin
MONEY FM 89.3
Your Money With Michelle Martin (9am - 12pm) It’s all about Your Money with Michelle Martin from 9am to 12pm. How to save, invest and make the best financial decisions for yourself. Listen to inspiring thinkers with “Influence” and hear from great authors in “Read”.
Episodes
Mentioned books

Apr 16, 2021 • 2min
Is copper the new oil?
On Market View Minute, Michelle Martin discusses a Goldman Sachs analysts theory that copper is the new oil and tells you how you can you cash in.See omnystudio.com/listener for privacy information.

Apr 16, 2021 • 14min
The Harvard Professor who for 20 year taught unicorn founders including Grab’s Anthony Tan on why some start-ups fail to thrive
Michelle Martin discusses the book The Fail-Safe Startup with author, Harvard Business School’s Tom Eisenmann.See omnystudio.com/listener for privacy information.

Apr 16, 2021 • 9min
Should you buy banking shares? What are the hot trends in Singapore’s property space ?
Why has Citigroup exited 13 global consumer banking markets including China? Is now a good time to buy banking shares? What are the trends in Singapore's property space that stand out? Michelle Martin and Ryan Huang discuss the latest news making headlines.See omnystudio.com/listener for privacy information.

Apr 15, 2021 • 3min
Coinbase, Goldman Sachs and Alchemy Technology
On Market View Minute, Michelle Martin discusses Coinbase's listing on its first day of trading and its valuation, Goldman Sach's record first quarter profits and Alchemy Technology.See omnystudio.com/listener for privacy information.

Apr 15, 2021 • 25min
Lojikfool on his 8 principals of investing
Alan Michael Mullins retired at the age of 42. His 18-year investment track record posts a gain of 1560%. This popular investor - known as Lojikfool on eTORO - has a following of some 550 copiers, some of whom have reaped gains of over 200% over five years. What are the 8 Principles that guide Logikfool's investment decision? Michelle Martin finds out.See omnystudio.com/listener for privacy information.

Apr 15, 2021 • 14min
What would have determined if you made money on Coinbase on Day 1? Earnings, American eagle , Dell and mm2 Asia
Why does the Coinbase listing matter? How was the Alkami IPO received? What’s driving JPMorgan Chase' business? Michelle Martin and Ryan Huang discuss the latest news making headlines. See omnystudio.com/listener for privacy information.

Apr 14, 2021 • 18min
Coinbase's valuation, Bitcoin as a Chinese financial weapon, the digital yuan and the semiconductor chip shortage
Michelle Martin and Jack Kouzi, Founder and Director of VFS Group discuss Coinbase's valuation and their business model, Bitcoin as a Chinese financial weapon, the Chinese digital yuan and an ETF to invest in the chip shortage. See omnystudio.com/listener for privacy information.

Apr 14, 2021 • 18min
Grab to list, FAVE purchased by India's Pine Labs, J&J's COVID vaccine may cause blood clots, US inflation and bond yields slip
Why has Grab chosen to go public through this route? What is happening with Fave in India? How will the suspension of Johnson and Johnson's COVID-19 vaccine impact the US' vaccination plans? Michelle Martin and Ryan Huang discuss the latest headlines making news.See omnystudio.com/listener for privacy information.

Apr 13, 2021 • 17min
Singapore's monetary policy expectations, Microsoft and Nuance's deal, Alibaba's fine, ANT restructuring and what it means for investors interested in Chinese tech
Will Singapore's central bank keep policy settings unchanged? What does the deal between Microsoft and Nuance Communications bring to Microsoft? What is the reaction to the fine for Alibaba? How is ANT restructuring? Michelle Martin and Tong Hoe Sng, Head of Wealth Management for Aura Group discuss. See omnystudio.com/listener for privacy information.

Apr 13, 2021 • 4min
New interest in Berkshire? Which Chinese platform is looking to avoid US China tensions and a COVID 19 breakthrough for a drug maker
On Market View Minute, Michelle Martin discusses what was behind the surge in Berkshire Hathaway, Trip.com plans a secondary listing and Regeneron's COVID-19 breakthrough.See omnystudio.com/listener for privacy information.


